Emerging evidence also suggests a critical role of BRD4 in the pathogenesis of several major lung diseases including acute lung injury such as acute respiratory distress syndrome (ARDS), asthma, pulmonary arterial hypertension (PAH), pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD). Here, BRD4 is linked to pulmonary arterial hypertension.